Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 When metformin fails in type 2 diabetes mellitus.

× No keyword cloud information.

7 in total

1. Does personalized diabetology overcome clinical uncertainty and therapeutic inertia in type 2 diabetes?

Authors: Katherine Esposito; Antonio Ceriello; Dario Giugliano
Journal: Endocrine Date: 2013-03-12 Impact factor: 3.633

2. A randomized, double-blind, placebo-controlled, phase II clinical trial to investigate the efficacy and safety of oral DA-1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise.

Authors: Chang Hee Jung; Cheol-Young Park; Kyu-Joeng Ahn; Nan-Hee Kim; Hak-Chul Jang; Moon-Kyu Lee; Joong-Yeol Park; Choon-Hee Chung; Kyung-Wan Min; Yeon-Ah Sung; Jeong-Hyun Park; Sung Jin Kim; Hyo Jung Lee; Sung-Woo Park
Journal: Diabetes Metab Res Rev Date: 2014-12-05 Impact factor: 4.876

Review 3. A nomogram to estimate the HbA1c response to different DPP-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of 98 trials with 24 163 patients.

Authors: Katherine Esposito; Paolo Chiodini; Maria Ida Maiorino; Annalisa Capuano; Domenico Cozzolino; Michela Petrizzo; Giuseppe Bellastella; Dario Giugliano
Journal: BMJ Open Date: 2015-02-16 Impact factor: 2.692

4. Pattern of Disease and Therapy for Diabetes along with Impact of Generic Prescribing on Cost of Treatment among Outpatients at a Tertiary Care Facility.

Authors: Shubham Atal; Rajnish Joshi; Sadasivam Balakrishnan; Pooja Singh; Zeenat Fatima; Nidhi Jain
Journal: J Pharm Bioallied Sci Date: 2020-12-16

5. Comparative evaluation of efficacy and safety of combination of metformin-vidagliptin versus metfromin-glimepiride in most frequently used doses in patients of type 2 diabetes mellitus with inadequately controlled metformin monotherapy-A randomised open label study.

Authors: Shallini Gupta; Vijay Khajuria; Vishal R Tandon; Annil Mahajan; Zahid H Gillani
Journal: Perspect Clin Res Date: 2015 Jul-Sep

Review 6. Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy--focus on alogliptin.

Authors: Annalisa Capuano; Liberata Sportiello; Maria Ida Maiorino; Francesco Rossi; Dario Giugliano; Katherine Esposito
Journal: Drug Des Devel Ther Date: 2013-09-17 Impact factor: 4.162

Review 7. Glycaemic durability with dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of long-term randomised controlled trials.

Authors: Katherine Esposito; Paolo Chiodini; Maria Ida Maiorino; Giuseppe Bellastella; Annalisa Capuano; Dario Giugliano
Journal: BMJ Open Date: 2014-06-10 Impact factor: 2.692

7 in total